المؤلفون: Lucchini E., Rusconi C., Levis M., Ricci F., Santoro A., Ricardi U., Volpetti S., Matrone F., Di Russo A., Caizzi M., Schiattarella A., Zaja F.

المساهمون: Lucchini, E., Rusconi, C., Levis, M., Ricci, F., Santoro, A., Ricardi, U., Volpetti, S., Matrone, F., Di Russo, A., Caizzi, M., Schiattarella, A., Zaja, F.

مصطلحات موضوعية: Hodgkin lymphoma, ICI-RT, Nivolumab, Pembrolizumab, Radiotherapy

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34221295; info:eu-repo/semantics/altIdentifier/wos/WOS:000661082200002; volume:13; issue:2; firstpage:"-"; lastpage:"-"; numberofpages:5; journal:HEMATOLOGY REPORTS; http://hdl.handle.net/11368/2994482Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85108854116; https://www.pagepress.org/journals/index.php/hr/article/view/9080Test

الإتاحة: https://doi.org/10.4081/hr.2021.9080Test
http://hdl.handle.net/11368/2994482Test
https://www.pagepress.org/journals/index.php/hr/article/view/9080Test

المؤلفون: Salvi F., Luminari S., Tucci A., Massidda S., Liberati A. M., Stelitano C., Zanni M., Re A., Centurioni R., Freilone R., Musuraca G., Nassi L., Patti C., Arcari A., Tani M., Pulsoni A., Pavone V., Volpetti S., Peli A., Evangelista A., Spina M., Ladetto M., Merli F.

المساهمون: Salvi F., Luminari S., Tucci A., Massidda S., Liberati A.M., Stelitano C., Zanni M., Re A., Centurioni R., Freilone R., Musuraca G., Nassi L., Patti C., Arcari A., Tani M., Pulsoni A., Pavone V., Volpetti S., Peli A., Evangelista A., Spina M., Ladetto M., Merli F.

مصطلحات موضوعية: cardiotoxicity, co-morbidity, elderly, Hodgkin lymphoma, liposomal doxorubicin

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31282794; info:eu-repo/semantics/altIdentifier/wos/WOS:000474836800001; volume:60; issue:12; firstpage:2890; lastpage:2898; numberofpages:9; journal:LEUKEMIA & LYMPHOMA; http://hdl.handle.net/2318/1732715Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85068729520; https://www.tandfonline.com/loi/ilal20Test

الإتاحة: https://doi.org/10.1080/10428194.2019.1608529Test
http://hdl.handle.net/2318/1732715Test
https://www.tandfonline.com/loi/ilal20Test

المؤلفون: Manuela Caizzi, Elisa Lucchini, Francesco Zaja, Anna Schiattarella, Stefano Volpetti, Armando Santoro, Mario Levis, Chiara Rusconi, Francesca Ricci, Fabio Matrone, Umberto Ricardi, Anna Di Russo

المساهمون: Lucchini, E., Rusconi, C., Levis, M., Ricci, F., Santoro, A., Ricardi, U., Volpetti, S., Matrone, F., Di Russo, A., Caizzi, M., Schiattarella, A., Zaja, F.

المصدر: Hematology Reports, Vol 13, Iss 2 (2021)
Hematology Reports
Hematology Reports; Volume 13; Issue 2; Pages: 9080

مصطلحات موضوعية: Oncology, medicine.medical_specialty, medicine.medical_treatment, Immune checkpoint inhibitors, Pembrolizumab, Article, Autologous stem-cell transplantation, ICI-RT, Refractory, Internal medicine, Classical Hodgkin lymphoma, medicine, polycyclic compounds, Diseases of the blood and blood-forming organs, Brentuximab vedotin, radiotherapy, Radiotherapy, Nivolumab, pembrolizumab, Hodgkin lymphoma, business.industry, Hematology, Radiation therapy, RC633-647.5, business, hormones, hormone substitutes, and hormone antagonists, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9c3f8eaf05ebdaf599685cfd6041faaTest
https://www.pagepress.org/journals/index.php/hr/article/view/9080Test